Fabrice Dunand

Fabrice Dunand is a seasoned professional with extensive experience in strategic planning and market intelligence within the pharmaceutical and biotechnology sectors. Currently serving as the Senior Director and Global Head of Early Stage Oncology at GSK since May 2024, Fabrice previously worked as a Strategy & Insights Consultant for various biotech and health tech companies. During a notable tenure at Ferring Pharmaceuticals from January 2014 to April 2022, Fabrice held multiple leadership roles, including Senior Director overseeing strategic planning, market intelligence, and as Secretary of the Group Operating Committee, contributing to business development and operational efficiencies. In addition, Fabrice has experience in representing industry interests and leading process optimization projects. Academically, Fabrice holds an MSc in Industrial Management and Manufacturing from ETH Zürich and has completed a program in Digital Strategy & Analytics at IMD.